Emerging LVAD Technology for the Use - Washington Hospital Center

More documents

Recommendations

Info

Jarvik 2000 ® VAS Destination Therapy Study: • IDE Study Protocol: in discussions with the FDA • Target initiation in 2012 • Study design: prospective, randomized against an approved DT LVAD • Study implant technique will include the Post-Auricular version of the Jarvik 2000 ® VAS
Future applications • Total Ventricular Assist (TVA or BVAD) applications RV & LV support in children RV support in adults Jarvik 2000 ® VAS
Page 1 and 2: Emerging LVAD Technologies for the
Page 3 and 4: Continuous Flow LVADs • Thoratec
Page 5 and 6: • Electrically powered • Percut
Page 7 and 8: • FDA approved Thoratec HeartMate
Page 9 and 10: Thoratec HeartMate III • Full-mag
Page 11 and 12: *In development and not available f
Page 13 and 14: HeartWare Ventricular Assist System
Page 17 and 18: Sintered HVAD Inlet
Page 19 and 20: HeartWare MVAD • Wide blade impel
Page 21 and 22: HeartWare MVAD Trans-Mitral “MVAD
Page 23: • Intraventricular axial flow pum
Page 27 and 28: MicroMed HeartAssist 5 ® VAD Heart
Page 29: CircuLite ® Synergy ® Micro-Pump
Page 33 and 34: Potential VAD Patient Opportunity U
Page 35: Are We Ready?
Page 41 and 42: Fully-Implantable System: Energy Tr
Page 43: • GLP animal studies completed He

Emerging LVAD Technology for the Use - Washington Hospital Center

Create successful ePaper yourself

Delete template?

Save as template?